Cargando…
Risk factors for cardiovascular disease among individuals with hepatic steatosis
Cardiovascular disease (CVD) is the leading cause of mortality in adults with hepatic steatosis (HS). However, risk factors for CVD in HS are unknown. We aimed to identify factors associated with coronary artery disease (CAD) and incident major adverse cardiovascular events (MACE) in individuals wit...
Autores principales: | Karády, Julia, Ferencik, Maros, Mayrhofer, Thomas, Meyersohn, Nandini M., Bittner, Daniel O., Staziaki, Pedro V., Szilveszter, Balint, Hallett, Travis R., Lu, Michael T., Puchner, Stefan B., Simon, Tracey G., Foldyna, Borek, Ginsburg, Geoffrey S., McGarrah, Robert W., Voora, Deepak, Shah, Svati H., Douglas, Pamela S., Hoffmann, Udo, Corey, Kathleen E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9701472/ https://www.ncbi.nlm.nih.gov/pubmed/36281983 http://dx.doi.org/10.1002/hep4.2090 |
Ejemplares similares
-
Lipoprotein Subclasses Associated With High‐Risk Coronary Atherosclerotic Plaque: Insights From the PROMISE Clinical Trial
por: McGarrah, Robert W., et al.
Publicado: (2022) -
Branched‐Chain Amino Acids in Computed Tomography–Defined Adipose Depots and Coronary Artery Disease: A PROMISE Trial Biomarker Substudy
por: Zhao, Elizabeth, et al.
Publicado: (2023) -
Associations of a polygenic risk score with coronary artery disease phenotypes in the Prospective Multicenter Imaging Study for Evaluation of Chest Pain (PROMISE) trial
por: Newman, Jonathan D., et al.
Publicado: (2022) -
Cost-effectiveness Analysis of Anatomic vs Functional Index Testing in Patients With Low-Risk Stable Chest Pain
por: Karády, Júlia, et al.
Publicado: (2020) -
Guideline-Based Statin Eligibility, Coronary Artery Stenosis and Cardiovascular Events in Patients with Stable Chest Pain: A Secondary Analysis of the PROMISE Randomized Clinical Trial
por: Pursnani, Amit, et al.
Publicado: (2020)